Rep. John R. Moolenaar

Maddy summaryHR 719, the "No Abortion Coverage for Medicaid Act," would prohibit federal Medicaid funds from covering abortions under any Medicaid demonstration projects or waivers, with limited exceptions. It specifically blocks federal financial assistance for abortion services or related expenses (like travel) in Medicaid programs, except in cases of rape or incest, life-threatening pregnancy conditions, or treatment for miscarriage or ectopic pregnancy. This bill directly affects Medicaid recipients in states participating in federal demonstration projects, preventing them from using Medicaid funds for abortion services except under the narrow exceptions listed. The bill aims to permanently align Medicaid funding with the longstanding Hyde Amendment restrictions.

Maddy summaryHR 727 amends federal law to expand the definition of "valuable consideration" in transactions involving human fetal tissue. The bill specifically adds provisions to prohibit payments, waived fees, canceled debts, or free/discounted services related to tissue transportation, processing, storage, or implantation. This directly affects medical providers, laboratories, and facilities handling fetal tissue by restricting how they can receive compensation for these services. The key change clarifies that even indirect financial benefits, like reduced charges or waived costs, would be considered prohibited "valuable consideration."

Maddy summaryHR 733 requires the President to review U.S. sanctions against 48 specific Hong Kong officials within 180 days of the bill's enactment. The review must determine if these officials - such as top government leaders (e.g., Chief Executive John Lee) and judicial figures (e.g., Chief Justice Andrew Cheung) - still meet criteria under four existing sanctions laws. The President must submit a detailed justification to congressional committees, including the Foreign Relations and Financial Services committees. This bill mandates a formal review process but does not alter current sanctions or guarantee any changes. The focus is solely on evaluating whether existing sanctions remain appropriate.

Life at Conception Act This bill declares that the right to life guaranteed by the Constitution is vested in each human being at all stages of life, including the moment of fertilization, cloning, or other moment at which an individual comes into being. Nothing in this bill shall be construed to authorize the prosecution of any woman for the death of her unborn child.

Maddy summaryHR 21, the Born-Alive Abortion Survivors Protection Act, requires medical staff at abortion facilities to provide the same immediate care and hospital admission to any infant born alive during an abortion as they would for any newborn. It mandates reporting failures to provide this care to law enforcement and imposes penalties of up to 5 years in prison for violations, with harsher penalties for intentional killing. The bill also allows women who undergo abortions to sue for civil damages, including triple the abortion cost, and provides for attorney fees. It defines "abortion" to exclude procedures performed after viability to preserve a live birth. This law directly affects healthcare providers at abortion facilities and creates new federal legal obligations for them.

Maddy summaryHRES 63 is a symbolic resolution designating the week of January 26-February 1, 2025, as "National School Choice Week." It expresses the House's support for raising public awareness about educational options - including public schools, charter schools, private schools, online academies, and homeschooling - and encourages parents to explore these choices. The resolution also urges the public to host events during this week to celebrate parental choice in education. As a non-binding resolution, it does not create new policies or alter existing laws.

Maddy summaryHR 679 nullifies specific changes the Food and Drug Administration (FDA) made in January 2023 to the safety rules (REMS) for the abortion pill mifepristone. The bill prohibits the FDA from implementing any future safety rules for mifepristone that are substantially similar to the nullified changes. This directly affects the FDA's regulatory authority over mifepristone, which could impact how healthcare providers prescribe the medication and how patients access it. The bill focuses solely on reversing the FDA's 2023 modifications without altering the drug's broader approval status.

Maddy summaryHR 685, the SAVE Moms and Babies Act of 2025, prohibits the FDA from approving new abortion drugs or allowing investigational use of existing ones. It restricts existing abortion drugs to in-person administration by certified healthcare providers in clinics or hospitals (not pharmacies), limits use to pregnancies under 70 days gestation, and requires providers to certify they can handle complications like severe bleeding or ectopic pregnancies. The bill mandates reporting of adverse events (such as hospitalizations or infections) to the FDA without patient identifiers and defines "abortion drug" broadly as any drug intended to terminate pregnancy, excluding specific medical exceptions. This directly affects FDA approval processes, healthcare providers prescribing these drugs, and drug manufacturers.

Maddy summaryThe Restoring Trade Fairness Act (HR 694) would suspend the United States' normal trade relations (NTR) status with China, ending the "permanent normal trade relations" (PNTR) status China has held since 2001. The bill requires the President to revise tariff rates for Chinese imports to apply minimum duties of 35% for most goods and 100% for specific listed items, with these increases phased in over five years. It also establishes a trust fund to compensate U.S. producers for revenue losses resulting from Chinese retaliation against U.S. exports, while modifying the U.S. Schedule of Concessions to the World Trade Organization.

Maddy summaryHR 703, the Main Street Tax Certainty Act, makes a key tax deduction permanent for small business owners. It removes the temporary sunset provision (subsection (i)) from Section 199A of the tax code, ensuring the qualified business income deduction remains available for eligible small businesses. This change directly affects pass-through business owners (like S-corps, partnerships, and sole proprietorships) who currently qualify for this deduction. The permanent change takes effect for tax years starting after December 31, 2025.